Pharmaceutical Care
Management Association
325 7th Street, NW
Washington, DC 20004
Main: 202.756.5700
©2024 PCMA. All Rights Reserved.
In case you missed it, an expert witness who testified before the U.S. House Committee on Oversight and Accountability during a hearing yesterday on pharmacy benefit companies underscored that misguided policies targeting pharmacy benefits will lead to higher prescription drug
This blog introduces a new series of blog posts that will look at interesting trends using the CMS’s historical Part D Star Ratings data, focusing on four measures of prescription drug adherence.
A simple fact is often lost in the din of the current drug pricing debate going on in Washington D.C. and around the country: Drug companies retain the great majority of the prescription drug dollar. What is the prescription drug
JC Scott President & Chief Executive Officer JC Scott is the President and CEO of the Pharmaceutical Care Management Association (PCMA), the national association representing America’s pharmacy benefit managers, or PBMs. PBMs administer prescription drug plans for more than 275
A simple fact is often lost in the din of the current drug pricing debate going on in Washington D.C. and around the country: Drug companies retain the great majority of the prescription drug dollar. What is the prescription drug
Biosimilars play an important role in lowering net costs.
Last month, the IQVIA Institute held a webinar, “The Use of Medicines in the U.S. 2023.” Panelists highlighted how big drug companies set the price of the drugs they create and have the power to lower costs, as well as the
The evidence is clear: pharmacy benefit companies lower prescription drug costs for employers, labor union plans, taxpayers, and patients. While big drug companies push a false narrative designed to shift attention and scrutiny for the high prices they set on
A new report by Milliman shows that over the 10-year period 2022-2031, if all manufacturer rebates were reflected at the point-of-sale in Medicare Part D, total beneficiary premiums could increase by an estimated $28.7 billion (16%) and total Federal government
©2024 PCMA. All Rights Reserved.